Looking Beyond Dose: Identifying Responders and Non-Responders to RehaCom Computerized Cognitive Rehabilitation in Progressive MS—The CogEx Study

= .71).ConclusionProcessing speed gains in progressive MS were related to both module-specific progression and participant characteristics, supporting a precision approach to cognitive rehabilitation that tailors training content to individual cognitive profiles. This study is a secondary analysis of the CogEx trial (ClinicalTrials.gov Identifier: NCT03679468; https://clinicaltrials.gov/ct2/show/NCT03679468).

Authors

Institutions

Publication Details

Journal
Neurorehabilitation and neural repair
Published
2026-04-25
DOI
https://doi.org/10.1177/15459683261432556
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Looking Beyond Dose: Identifying Responders and Non-Responders to RehaCom Computerized Cognitive Rehabilitation in Progressive MS—The CogEx Study

M Filippi, Jeremy Chataway, Nancy D. Chiaravalloti, Cecilia Meza et al.
Neurorehabilitation and neural repair
Multiple Sclerosis Research Studies
article

Looking Beyond Dose: Identifying Responders and Non-Responders to RehaCom Computerized Cognitive Rehabilitation in Progressive MS—The CogEx Study

M Filippi, Jeremy Chataway, Nancy D. Chiaravalloti, Cecilia Meza, Silvana L. Costa, Rachel Farrell, Amber R. Salter, Peter Feys, Ulrik Dalgas, Brian M. Sandroff, R. Hernandez, Maria Assunta Rocca, Jennifer Freeman, Matilde Inglese, Giampaolo Brichetto, Anthony Feinstein, Robert W. Motl, Gary Cutter, Maria Pia Amato, John DeLuca
article en

Abstract

= .71).ConclusionProcessing speed gains in progressive MS were related to both module-specific progression and participant characteristics, supporting a precision approach to cognitive rehabilitation that tailors training content to individual cognitive profiles. This study is a secondary analysis of the CogEx trial (ClinicalTrials.gov Identifier: NCT03679468; https://clinicaltrials.gov/ct2/show/NCT03679468).

Neurorehabilitation and neural repair
Rutgers, The State University of New Jersey (US), St. Michael's Hospital (CA), Sunnybrook Health Science Centre (CA), Vita-Salute San Raffaele University (IT), Queen Mary University of London (GB), University of Toronto (CA), Aarhus University (DK), Kessler Foundation (US), Health Sciences Centre (CA), University of Alabama at Birmingham (US), National Institute for Health and Care Research (GB), University of Illinois Chicago (US), Associazione Italiana Sclerosi Multipla (IT), National Hospital for Neurology and Neurosurgery (GB), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Statistical Research (United States) (US), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), Rutgers New Jersey Medical School (US), University of Florence (IT), University College London (GB), University of Genoa (IT), Hasselt University (BE), University of Plymouth (GB)
Multiple Sclerosis Society of Canada
Openalex Percentile: Top 17%
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.